Lobbying Activity Report

2606-34225

Organization: sanofi-aventis Canada Inc.
Was this lobbying activity a letter sent on behalf of one or more of the organizations listed as members of a coalition in your Registration Return? No
Associated registration: 8767-2606-18
Lobbying Activity date: 2024-03-12
Arranged a meeting: No
Posted date: 2024-04-15

In-house lobbyists who participated in the lobbying activity: Daniel Kennedy
Senior Public Office Holders who were lobbied in this activity: Shirley Bond, MLA for Prince George-Valemount
Member(s) of the BC Legislative Assembly Footnote1
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Discuss BC PharmaCare and BC Ministry of Health Policy Initiatives and their impact on Sanofi in the province.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health
To actively promote the contributions and positive impact of pharmaceutical innovation and the innovative pharmaceutical industry in British Columbia and to increase awareness of the value of innovative therapies on the healthcare system. Ensure any changes to pharmaceutical legislation support appropriate government reimbursement of innovative pharmaceuticals.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health
 
Senior officer who filed this Lobbying Activity Report: Stephanie Veyrun-Manetti
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
 
  1. Footnote1  Indicates new information that was added through a Lobbying Activity Report.
Date Modified: